Bhubaneshwar (Odisha) [India], March 2: Manipal Hospital Bhubaneswar hosted a press meet on 24th February, 2026 reinforcing its reputation as a leading hub for liver transplantation backed by years of clinical expertise. The event highlighted the growing liver disease burden in Odisha, where
The Researchers at the University of California San Diego School of Medicine have identified a new investigational drug that shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease linked to obesity and type 2 diabetes that can
Raichur (Karnataka) [India], March 12: Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug (IND) - Nor Ursodeoxycholic Acid (Nor UDCA) Tablets
Greater Noida (Uttar Pradesh) [India], November 15: School of Medical Sciences and Research (SMS&R) at Sharda Hospital successfully organised the first, National Multidisciplinary Conference on Recent Advances in Medical Specialties at the Anand Swaroop Auditorium, on 13th and 14th Novem
Coimbatore (Tamil Nadu) [India], August 31: The liver experts at Sri Ramakrishna Hospital recognize the silent emergency of alcohol induced liver problems, offering insights to this extremely preventable condition. The Hepatology Department at Sri Ramakrishna Hospital is well-equipped to dia
The failure of the liver as a crucial organ is becoming more common due to fatty liver disease, often known as steatotic liver disease or SLD for short. Researchers have now found that a saturated fatty acid in blood vessels causes the synthesis of the signalling molecule SEMA3A, which shuts
The efficacy of a medication to prevent liver fat accumulation--a condition that frequently coexists with obesity and can result in dangerous fatty liver disease--has been further explored by researchers at the University of Oklahoma.
Fatty liver disease frequently causes chronic liver inflammation and can possibly result in liver cancer. Scientists at the German Cancer Research Centre (DKFZ) and the University of Tubingen have demonstrated in mice that intermittent fasting on a 5:2 schedule can block this progression.
New research from Sweden's Karolinska Institutet demonstrates how oestrogen protects against MASLD, a fatty liver disease that has developed rapidly during the obesity epidemic. The study, published in the journal Molecular Systems Biology, demonstrates how a new medicine under development c
Ahmedabad (Gujarat) [India], November 3: Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as "Zydus") a discovery-driven, global lifesciences company and Lupin Limited (Lupin), a global pharma major, today announced that they have entered into a licensi
Resistant starch is a nondigestible fibre that ferments in the large intestine and has previously been found to boost metabolism in animal tests.
A 4-month randomised controlled experiment in persons with non-alcoholic fatty liver disease (NAFLD) found that regularly eating resistant starch